|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| A61K 31/454 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| G01N 33/50 | (2006.01) | ||
| A61K 31/517 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| C12Y 207/11001 | (2013.01) | ||
| A61K 38/21 | (2006.01) | ||
| G01N 33/6863 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 38/21 | (2013.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 1/16 | (2018.01) |
| (11) | Number of the document | 3077548 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14868331.1 |
| Date of filing the European patent application | 2014-12-05 | |
| (97) | Date of publication of the European application | 2016-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/068795 |
| Date | 2014-12-05 |
| (87) | Number | WO 2015/085172 |
| Date | 2015-06-11 |
| (30) | Number | Date | Country code |
| 201361913003 P | 2013-12-06 | US | |
| 201461947963 P | 2014-03-04 | US | |
| 201461990621 P | 2014-05-08 | US | |
| 201462061050 P | 2014-10-07 | US | |
| 201462064413 P | 2014-10-15 | US | |
| 201462077835 P | 2014-11-10 | US | |
| 201462087111 P | 2014-12-03 | US |
| (72) |
TROTTER, Matthew William, Burnell , ES
HAGNER, Patrick , US
HAVENS, Courtney, G. , US
CHOPRA, Rajesh , GB
GANDHI, Anita , US
KLIPPEL, Anke , US
WANG, Maria, Yinglin , US
BREIDER, Mike , US
COUTO, Suzana, Sturlini , US
REN, Yan , US
HOLLENBACH, Paul , US
MACBETH, Kyle , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS |
| METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS |